This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
See you next year! September 15-18, 2025
Hynes Convention CenterBoston, MA
Menu

Yogapriya Murugesan
Scientist I at Biogen
Speaker

Agenda Sessions

  • Comparing the Outlook of Developability Assessment of Monoclonal Antibodies to AAV Therapeutics for Successful Lead Candidate Selection from Discovery to Development

    , 3:00pm
    View Session

At this event

Prev
Next
Dethardt Müller
Chief Technology Officer - CMC
Abalos Therapeutics GmbH

See Yogapriya at Cell & Gene Therapy International